These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25301960)

  • 1. A fusogenic dengue virus-derived peptide enhances antitumor efficacy of an antibody-ribonuclease fusion protein targeting the EGF receptor.
    Kiesgen S; Liebers N; Cremer M; Arnold U; Weber T; Keller A; Herold-Mende C; Dyckhoff G; Jäger D; Kontermann RE; Arndt MA; Krauss J
    Protein Eng Des Sel; 2014 Oct; 27(10):331-7. PubMed ID: 25301960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity and toxicity of anti-HER2 immunoRNase scFv 4D5-dibarnase in mice bearing human breast cancer xenografts.
    Balandin TG; Edelweiss E; Andronova NV; Treshalina EM; Sapozhnikov AM; Deyev SM
    Invest New Drugs; 2011 Feb; 29(1):22-32. PubMed ID: 19789841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An EGF receptor targeting Ranpirnase-diabody fusion protein mediates potent antitumour activity in vitro and in vivo.
    Kiesgen S; Arndt MAE; Körber C; Arnold U; Weber T; Halama N; Keller A; Bötticher B; Schlegelmilch A; Liebers N; Cremer M; Herold-Mende C; Dyckhoff G; Federspil PA; Jensen AD; Jäger D; Kontermann RE; Mier W; Krauss J
    Cancer Lett; 2015 Feb; 357(1):364-373. PubMed ID: 25434798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity.
    Fernández-Ulibarri I; Hammer K; Arndt MA; Kaufmann JK; Dorer D; Engelhardt S; Kontermann RE; Hess J; Allgayer H; Krauss J; Nettelbeck DM
    Int J Cancer; 2015 May; 136(9):2228-40. PubMed ID: 25303768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor efficacy of the scFv-based fusion protein and its enediyne-energized analogue directed against epidermal growth factor receptor.
    Sheng W; Shang Y; Miao Q; Li Y; Zhen Y
    Anticancer Drugs; 2012 Apr; 23(4):406-16. PubMed ID: 22205154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and purification of a toxin-linked conjugate targeting epidermal growth factor receptor in Escherichia coli.
    Ma C; Li Y; Li Z; Huang H; Xu K; Xu H; Bai J; Li X; Zhao G
    Protein Expr Purif; 2012 May; 83(1):1-7. PubMed ID: 22381467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An EGFR/CD13 bispecific fusion protein and its enediyne-energized analog show potent antitumor activity.
    Sheng W; Shang Y; Li L; Zhen Y
    Anticancer Drugs; 2014 Jan; 25(1):82-91. PubMed ID: 24100279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel fully human antitumor immunoRNase resistant to the RNase inhibitor.
    Riccio G; D'Avino C; Raines RT; De Lorenzo C
    Protein Eng Des Sel; 2013 Mar; 26(3):243-8. PubMed ID: 23232187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient killing of CD22+ tumor cells by a humanized diabody-RNase fusion protein.
    Krauss J; Arndt MA; Vu BK; Newton DL; Seeber S; Rybak SM
    Biochem Biophys Res Commun; 2005 Jun; 331(2):595-602. PubMed ID: 15850802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endosomal escape efficiency of fusogenic B18 and B55 peptides fused with anti-EGFR single chain Fv as estimated by nuclear translocation.
    Niikura K; Horisawa K; Doi N
    J Biochem; 2016 Jan; 159(1):123-32. PubMed ID: 26338729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new RNase-based immunoconjugate selectively cytotoxic for ErbB2-overexpressing cells.
    De Lorenzo C; Nigro A; Piccoli R; D'Alessio G
    FEBS Lett; 2002 Apr; 516(1-3):208-12. PubMed ID: 11959134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel strategy for engineering of a smart generation of immune ribonucleases against EGFR
    Taghizadegan N; Firoozrai M; Nassiri M; Ariannejad H
    J Cell Physiol; 2021 Jun; 236(6):4303-4312. PubMed ID: 33421131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F.
    Woitok M; Klose D; Niesen J; Richter W; Abbas M; Stein C; Fendel R; Bialon M; Püttmann C; Fischer R; Barth S; Kolberg K
    Cancer Lett; 2016 Oct; 381(2):323-30. PubMed ID: 27502168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion of a furin-sensitive spacer enhances the cytotoxicity of ribotoxin restrictocin containing recombinant single-chain immunotoxins.
    Goyal A; Batra JK
    Biochem J; 2000 Jan; 345 Pt 2(Pt 2):247-54. PubMed ID: 10620501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFR.
    Zhou Y; Zhang J; Jin H; Chen Z; Wu Q; Li W; Yue M; Luo C; Wang M
    Biomed Pharmacother; 2013 Oct; 67(8):737-43. PubMed ID: 23639232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IgM CH2 domain as covalently linked homodimerization module for the generation of fusion proteins with dual specificity.
    Seifert O; Plappert A; Heidel N; Fellermeier S; Messerschmidt SK; Richter F; Kontermann RE
    Protein Eng Des Sel; 2012 Oct; 25(10):603-12. PubMed ID: 22988132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNAP-tag technology mediates site specific conjugation of antibody fragments with a photosensitizer and improves target specific phototoxicity in tumor cells.
    Hussain AF; Kampmeier F; von Felbert V; Merk HF; Tur MK; Barth S
    Bioconjug Chem; 2011 Dec; 22(12):2487-95. PubMed ID: 21995499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocell targeting using engineered bispecific antibodies.
    Taylor K; Howard CB; Jones ML; Sedliarou I; MacDiarmid J; Brahmbhatt H; Munro TP; Mahler SM
    MAbs; 2015; 7(1):53-65. PubMed ID: 25523746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Expression in Escherichia coli of a Single-Domain Antibody-Tumor Necrosis Factor α Fusion Protein Specific for Epidermal Growth Factor Receptor.
    Osaki T; Nakanishi T; Aoki M; Omizu T; Nishiura D; Kitamura M
    Monoclon Antib Immunodiagn Immunother; 2018 Feb; 37(1):20-25. PubMed ID: 29474158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and characterization of recombinant humanized anti-HER2 single-chain antibody in Pichia pastoris for targeted cancer therapy.
    Cao X; Yu H; Chen C; Wei J; Wang P
    Biotechnol Lett; 2015 Jul; 37(7):1347-54. PubMed ID: 25735855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.